# Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation

> **NCT04331145** · PHASE4 · COMPLETED · sponsor: **Andres Iñiguez Romo** · enrollment: 40 (actual)

## Conditions studied

- Symptomatic Aortic Stenosis

## Interventions

- **DRUG:** Ticagrelor 60mg

## Key facts

- **NCT ID:** NCT04331145
- **Lead sponsor:** Andres Iñiguez Romo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2021-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04331145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04331145, "Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04331145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*